Literature DB >> 16637013

Possible dysregulation of chaperon and metabolic proteins in cystic fibrosis bronchial tissue.

Thomas Frischer1, Jae-Kyung Myung, Gerald Maurer, Irmgard Eichler, Zsolt Szepfalusi, Gert Lubec.   

Abstract

Cystic fibrosis (CF) is an autosomal recessive disease due to mutations of the CF transmembrane conductance regulator gene. A systematic approach to generate a protein expressional pattern in CF bronchial tissue has not been performed so far. It was the aim of this hypothesis-generating study to construct differential proteomes of bronchial biopsies in controls (n = 8) and CF patients (n = 9). Biopsies (pools of three per patient) were taken; proteins were extracted and run on 2-DE with subsequent in-gel digestion and mass spectrometrical identification and quantification of proteins using specific software. Three hundred sixty-six protein spots were identified and compared between groups. Following an approach for multiple testing correction, the chaperone 75 kDa glucose-regulated protein and ubiquinol-cytochrome c reductase complex core protein I and one form of nidogen, a pseudogene of aconitase 2, were increased in CF (p < 0.005). Aberrant protein levels may reflect molecular changes of CF as well as CF-linked inflammation, infection and cellular stress response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16637013     DOI: 10.1002/pmic.200500487

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

Review 1.  A proteomic primer for the clinician.

Authors:  Yurong Guo; Zongming Fu; Jennifer E Van Eyk
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 2.  Applications of proteomic technologies for understanding the premature proteolysis of CFTR.

Authors:  Mark J Henderson; Om V Singh; Pamela L Zeitlin
Journal:  Expert Rev Proteomics       Date:  2010-08       Impact factor: 3.940

3.  Mass spectrometrical characterization of NDRG2 protein (N-myc-downstream regulated gene 2) and description of two novel phosphorylation sites.

Authors:  Wei-Qiang Chen; Harald Hoeger; Wei-Fei Diao; Arnold Pollak; Gert Lubec
Journal:  Neurochem Res       Date:  2007-06-15       Impact factor: 3.996

4.  Serotonin(1A)-receptor-dependent signaling proteins in mouse hippocampus.

Authors:  Lin Li; Nigel Whittle; Stefanie Klug; Wei-Qiang Chen; Nicolas Singewald; Miklos Toth; Gert Lubec
Journal:  Neuropharmacology       Date:  2009-07-14       Impact factor: 5.250

5.  Analysis of the liver soluble proteome from bull terriers affected with inherited lethal acrodermatitis.

Authors:  Arthur Grider; Michael F Mouat; Elizabeth A Mauldin; Margret L Casal
Journal:  Mol Genet Metab       Date:  2007-08-10       Impact factor: 4.797

6.  Protein biomarkers in cystic fibrosis research: where next?

Authors:  Sally H Pattison; J Stuart Elborn
Journal:  Genome Med       Date:  2010-12-16       Impact factor: 11.117

Review 7.  The proteomics of lung injury in childhood: challenges and opportunities.

Authors:  Prue M Pereira-Fantini; David G Tingay
Journal:  Clin Proteomics       Date:  2016-02-29       Impact factor: 3.988

Review 8.  Biomarkers of lung-related diseases: current knowledge by proteomic approaches.

Authors:  Andy T Y Lau; Jen-Fu Chiu
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

Review 9.  Proteomics and Metabolomics for Cystic Fibrosis Research.

Authors:  Nara Liessi; Nicoletta Pedemonte; Andrea Armirotti; Clarissa Braccia
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.